Form D · Hedge Fund
Confluent Biotech Capital Partners, LP
Teaneck, NJ · CIK 0001651358
Offering snapshot reported Sep 25, 2019 · SEC filing
- Reported sold
- $1.3M Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jan 1, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2019 | Amendment | $1,300,000 | $0vs Sep 19, 2018 | 5 | SEC filing |
| Sep 19, 2018 | Amendment | $1,300,000 | $50,000vs Sep 19, 2017 | 5 | SEC filing |
| Sep 19, 2017 | Amendment | $1,250,000 | $0vs Sep 19, 2016 | 4 | SEC filing |
| Sep 19, 2016 | Amendment | $1,250,000 | No comparison | 4 | SEC filing |
| Sep 17, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-247837
Source: Form D, filed Sep 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Brothman | Director |
| Steven Furer | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Teaneck, NJ, 07666